Optas LLC’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $358K | Sell |
5,193
-126
| -2% | -$8.7K | 0.07% | 188 |
|
|
2025
Q1 | $369K | Sell |
5,319
-940
| -15% | -$65.3K | 0.06% | 158 |
|
|
2024
Q4 | $538K | Buy |
6,259
+614
| +11% | +$52.8K | 0.12% | 105 |
|
|
2024
Q3 | $672K | Sell |
5,645
-118
| -2% | -$14.1K | 0.15% | 84 |
|
|
2024
Q2 | $823K | Buy |
5,763
+43
| +0.8% | +$6.14K | 0.21% | 61 |
|
|
2024
Q1 | $734K | Buy |
5,720
+16
| +0.3% | +$2.05K | 0.2% | 70 |
|
|
2023
Q4 | $590K | Buy |
5,704
+286
| +5% | +$29.6K | 0.18% | 76 |
|
|
2023
Q3 | $493K | Buy |
5,418
+152
| +3% | +$13.8K | 0.16% | 88 |
|
|
2023
Q2 | $426K | Buy |
5,266
+156
| +3% | +$12.6K | 0.14% | 96 |
|
|
2023
Q1 | $407K | Buy |
5,110
+240
| +5% | +$19.1K | 0.15% | 98 |
|
|
2022
Q4 | $330K | Buy |
4,870
+22
| +0.5% | +$1.49K | 0.14% | 99 |
|
|
2022
Q3 | $242K | Buy |
4,848
+140
| +3% | +$6.99K | 0.11% | 117 |
|
|
2022
Q2 | $263K | Buy |
4,708
+454
| +11% | +$25.4K | 0.11% | 112 |
|
|
2022
Q1 | $236K | Buy |
+4,254
| New | +$236K | 0.08% | 131 |
|